Data for ST003920
| Metabolite structure | All data | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D9-gammabutyrobetaine | 4224339.85 | 29939151.60 | - | - | - | - | 784916.44 | 452463.11 | - | - | - | - | - | - | ||
| D9-hydroxytrimethyllysine | - | - | - | - | - | - | 32614.22 | 16663.56 | - | - | - | - | - | - | ||
| D9-L-carnitine | - | - | - | - | - | - | 93363.56 | 45751.62 | - | - | - | - | - | - | ||
| D9-Trimethyllysine | 22002158.40 | 15994924.20 | 7914150.38 | 12359407.44 | 4267597.19 | 6439410.76 | - | - | 1785404.89 | 5993937.86 | - | - | - | - | ||
| Dimethylarginine | - | - | - | - | - | - | - | - | - | - | 3452430.00 | - | 7232136.56 | - | ||
| gamma-butyrobetaine | 69080320.80 | 118764524.80 | - | - | - | - | - | - | - | - | - | 33600382.80 | - | 20404686.40 | ||
| L-carnitine | - | - | 3716320.20 | 77916096.31 | - | - | - | - | 8157485.56 | 25645573.37 | - | 108908289.60 | - | 83348758.40 | ||
| L-gulonolactone | - | - | - | - | - | - | - | - | - | - | 76811809.64 | - | 47159914.74 | - | ||
| L-lysine | - | - | - | - | - | - | - | - | - | - | 100580813.14 | 13661284.20 | 159697159.34 | 18485540.60 | ||
| L-tryptophan | - | - | - | - | - | - | - | - | - | - | 303026547.99 | - | 481328536.06 | - | ||
| Methionine | - | - | - | - | - | - | - | - | - | - | 83700517.09 | - | 126406667.57 | - | ||
| oxoglutarate | - | - | - | - | - | - | - | - | - | - | 20260948.35 | - | 8537048.68 | - | ||
| Trimethyllysine | 2869856.05 | 1888693.90 | - | - | - | - | - | - | - | - | 44965571.58 | 7124237.50 | 89781183.88 | 11195268.00 |
Factors:
| F1 | Sample source:293 cells | Sample type:293 cells | Genotype:Control | Treatment:10 uM D9-TML |
| F2 | Sample source:293 cells | Sample type:293 cells | Genotype:Overexpression | Treatment:10 uM D9-TML |
| F3 | Sample source:293 Mito | Sample type:293 Mito | Genotype:KO | Treatment:10 uM D9-TML |
| F4 | Sample source:293 Mito | Sample type:293 Mito | Genotype:Rescue | Treatment:10 uM D9-TML |
| F5 | Sample source:Ecoli | Sample type:Ecoli | Genotype:Control | Treatment:10 uM D9-TML |
| F6 | Sample source:Ecoli | Sample type:Ecoli | Genotype:Overexpression | Treatment:10 uM D9-TML |
| F7 | Sample source:Hepatocytes | Sample type:Hepatocytes | Genotype:Control | Treatment:10 uM D9-TML |
| F8 | Sample source:Hepatocytes | Sample type:Hepatocytes | Genotype:KO | Treatment:10 uM D9-TML |
| F9 | Sample source:Ing Mito | Sample type:Ing Mito | Genotype:Cre | Treatment:10 uM D9-TML |
| F10 | Sample source:Ing Mito | Sample type:Ing Mito | Genotype:Ctl | Treatment:10 uM D9-TML |
| F11 | Sample source:Serum | Sample type:Serum | Genotype:Control | Treatment:72h 6C |
| F12 | Sample source:Serum | Sample type:Serum | Genotype:Control | Treatment:None |
| F13 | Sample source:Serum | Sample type:Serum | Genotype:KO | Treatment:72h 6C |
| F14 | Sample source:Serum | Sample type:Serum | Genotype:KO | Treatment:None |
| F15 | Sample source:Serum | Sample type:Serum | Genotype:Slc25a45AlbKO | Treatment:72h 6C |
